About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,621 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,621 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5061-5080 of 6,621 trials

CompletedComparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B LymphomaThe aim of the study is to compare the diagnostic performance of whole-body MRI scan, positron emission tomography + CT, and circulating tumor DNA in patients with hematologic…NCT06777290·Prague, Prague TerminatedStudy of GS-0189 (Formerly FSI-189) as Monotherapy and in Combination With Rituximab in Participants With Relapsed/Refractory Non-Hodgkin LymphomaThe primary objective of this study is to determine the safety and tolerability of GS-0189 (formerly FSI-189) as monotherapy and in combination with rituximab in participants with…NCT04502706·Birmingham, Alabama and 4 others Not yet recruitingPositron Emission Tomography (PET) Imaging of Chemotherapy-Induced CardiotoxicityThis study is a single center, phase 1 clinical imaging study designed to assess the role of 68Ga-Galmydar Positron Emission Tomography (PET) imaging for detection of…NCT07838649·St Louis, Missouri RecruitingA Cohort Study in Newly Diagnosed MZLDescribe the clinical features, diagnosis and treatment status, disease course and primary outcomes of different subtypes of marginal zone B-cell lymphoma (MZL), observe the…NCT06449885·Shanghai, Shanghai Municipality

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

Active not recruitingProvision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior TransplantationThis study seeks to examine treatment therapy that will reduced regimen-related toxicity and relapse while promoting rapid immune reconstitution with limited serious…NCT02790515·Memphis, Tennessee

CompletedForodesine in the Treatment of Cutaneous T-Cell LymphomaThis is a Phase II, non-randomized, open-label, single-arm trial that will be conducted at up to 50 sites in North America, Europe and Australia.NCT00501735·Birmingham, Alabama and 40 others

CompletedEscalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's MacroglobulinemiaThe purpose of this study is to evaluate the safety and tolerability of AVL-292 as monotherapy in subjects with relapsed or refractory B cell non-Hodgkin lymphoma (B-NHL), chronic…NCT01351935·Huntsville, Alabama and 12 others

CompletedLMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or LymphomaRATIONALE: LMB-2 immunotoxin can locate cancer cells and kill them without harming normal cells.NCT00085150·Atlanta, Georgia and 4 others

Not yet recruitingAutologous Bedside CD19 CAR T-cell Therapy for B-ALLThe purpose of this clinical trial is to learn if autologous bedside CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy works to treat B-cell acute lymphoblastic…NCT07277504·Chengdu, Sichuan

UnknownSafety and Efficacy Study of Bendamustine to Treat Non-Hodgkin LymphomaThe purpose of this study is to determine whether bendamustine HCl for injection is safe and effective in the treatment of Rituximab refractory or relapsed B-cell indolent…NCT01570049·Tianjin, Tianjin Municipality and 1 other

TerminatedCombination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.NCT00060385·Leuven

CompletedA Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell LymphomaThe purpose of this study is to evaluate the efficacy and safety of ibrutinib given in combination with bendamustine and rituximab in patients 65 years of age or older with newly…NCT01776840·Tucson, Arizona and 200 others

UnknownGPED for Patients With Relapsed/Refractory or Advanced NK/T-cell LymphomaThe purpose of this study is to evaluate the efficacy and safety of GPED (gemcitabine, pegaspargase, etoposide, and dexamethasone) regimen in the treatment of Relapsed/Refractory…NCT04917250·Beijing

TerminatedEtoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin LymphomaThis clinical trial studies etoposide, filgrastim and plerixafor in improving stem cell mobilization in patients with non-Hodgkin lymphoma.NCT01408043·Cleveland, Ohio

RecruitingPre-malignant States to Hematologic Malignancies in FirefightersThe purpose of the study is to evaluate if firefighter exposure to hazardous compounds will increase the incidence of premalignant hematological states which subsequently…NCT06870760·Charlotte, North Carolina

TerminatedCD19-Specific T Cells Post AlloSCTThis phase I trial investigates the side effects and best dose of CD19 positive (+) specific CAR-T cells in treating patients with CD19+ lymphoid malignancies, such as acute…NCT03579888·Houston, Texas

UnknownGenotype-guided Treatment in DLBCLA multicenter, prospective, randomized, open-label, controlled trial to evaluate the efficacy and safety of genotype-guided targeted agents plus rituximab-cyclophosphamide…NCT05351346·Shanghai, Shanghai Municipality

CompletedBTK Inhibitor DTRMWXHS-12 in Mantle Cell LymphomaThe Primary Objective is to evaluate the safety and tolerability of the DTRMWXHS-12 capsule in patients with relapsed/refractory MCL and recommend the dose and dosing method…NCT03836768·Beijing

CompletedLife Satisfaction and Psychopathology in Institutionalized Elderly PeopleThe present study attempted to test the benefits of a Mindfulness-Based Stress Reduction (MBSR) program in Portuguese institutionalized elderly people, as a way to improve life…NCT02774018

TerminatedDA-EPOCH-Rituximab/Metformin (RM) for Double Hit LymphomaNewly diagnosed histologically confirmed c-myc+ de novo DLBCL.NCT02815397·Chicago, Illinois

PreviousPage 254 of 332Next